According to @StockMKTNewz, CNBC reports that Amazon AMZN said it now offers Novo Nordisk NVO Wegovy weight-loss drug through its Amazon Pharmacy digital service. Source: CNBC. Wegovy is an FDA-approved GLP-1 therapy for chronic weight management, underscoring its role within the obesity drug category tracked by healthcare equity traders. Source: U.S. Food and Drug Administration. The CNBC report did not indicate any direct cryptocurrency market impact from this rollout, suggesting no immediate crypto-market catalyst from the development. Source: CNBC.